Share this
PhaseBio Pharmaceuticals – $46 Million IPO
Entasis Therapeutics – $75 Million IPO
Autolus – $173 Million IPO
Sucampo Sells to Mallinckrodt for $1.2 Billion
Cardioxyl Pharmaceuticals sale to Bristol-Myers Squibb
First US IPO of 2014 for GlycoMimetics
MaxCyte – $202 Million IPO
LAVA Therapeutics – $107 Million IPO
Stori Closes One of Latin America’s Largest Series C Rounds